Publication
2026
- Azevedo, A. et al. 2026. Expression of RUNX1::RUNX1T1 deregulates the proteome, induces C/EBPβ suppression and blocks myeloid differentiation. Blood Neoplasia 3 (3) 100259. (10.1016/j.bneo.2026.100259)
- Cruz Santos, M. et al. 2026. Autism-relevant oxysterol signaling regulates GABAergic neurogenesis and interneuron subtype specification. Translational Psychiatry (10.1038/s41398-026-04396-6)
2022
- Menezes, A. C. et al. 2022. Increased expression of RUNX3 inhibits normal human myeloid development. Leukemia 36 , pp.1769-1780. (10.1038/s41375-022-01577-2)
- Nicholson, R. et al. 2022. Protein kinase C epsilon overexpression is associated with poor patient outcomes in AML and promotes daunorubicin resistance through p-glycoprotein-mediated drug efflux. Frontiers in Oncology 12 840046. (10.3389/fonc.2022.840046)
- Menezes, A. C. et al. 2022. RUNX3 overexpression inhibits normal human erythroid development. Scientific Reports 12 1243. (10.1038/s41598-022-05371-z)
2019
- Morgan, R. G. et al., 2019. LEF-1 drives aberrant B-catenin nuclear localization in myeloid leukemia cells. Haematologica 104 , pp.1365-1377. 202846. (10.3324/haematol.2018.202846)
2013
- Morgan, R. G. et al. 2013. γ-Catenin is overexpressed in acute myeloid leukemia and promotes the stabilization and nuclear localization of β-catenin. Leukemia 27 (2), pp.336-343. (10.1038/leu.2012.221)
2009
- Morgan, L. D. et al. 2009. Elevated Src kinase activity attenuates tamoxifen response in vitro and is associated with poor prognosis clinically. Cancer Biology and Therapy 8 (16), pp.1550-1558. (10.4161/cbt.8.16.8954)
2007
- Taylor, K. M. et al. 2007. The emerging role of the LIV-1 subfamily of zinc transporters in breast cancer. Molecular Medicine 13 (7-8), pp.396-406.
Articles
- Azevedo, A. et al. 2026. Expression of RUNX1::RUNX1T1 deregulates the proteome, induces C/EBPβ suppression and blocks myeloid differentiation. Blood Neoplasia 3 (3) 100259. (10.1016/j.bneo.2026.100259)
- Cruz Santos, M. et al. 2026. Autism-relevant oxysterol signaling regulates GABAergic neurogenesis and interneuron subtype specification. Translational Psychiatry (10.1038/s41398-026-04396-6)
- Menezes, A. C. et al. 2022. Increased expression of RUNX3 inhibits normal human myeloid development. Leukemia 36 , pp.1769-1780. (10.1038/s41375-022-01577-2)
- Nicholson, R. et al. 2022. Protein kinase C epsilon overexpression is associated with poor patient outcomes in AML and promotes daunorubicin resistance through p-glycoprotein-mediated drug efflux. Frontiers in Oncology 12 840046. (10.3389/fonc.2022.840046)
- Menezes, A. C. et al. 2022. RUNX3 overexpression inhibits normal human erythroid development. Scientific Reports 12 1243. (10.1038/s41598-022-05371-z)
- Morgan, R. G. et al., 2019. LEF-1 drives aberrant B-catenin nuclear localization in myeloid leukemia cells. Haematologica 104 , pp.1365-1377. 202846. (10.3324/haematol.2018.202846)
- Morgan, R. G. et al. 2013. γ-Catenin is overexpressed in acute myeloid leukemia and promotes the stabilization and nuclear localization of β-catenin. Leukemia 27 (2), pp.336-343. (10.1038/leu.2012.221)
- Morgan, L. D. et al. 2009. Elevated Src kinase activity attenuates tamoxifen response in vitro and is associated with poor prognosis clinically. Cancer Biology and Therapy 8 (16), pp.1550-1558. (10.4161/cbt.8.16.8954)
- Taylor, K. M. et al. 2007. The emerging role of the LIV-1 subfamily of zinc transporters in breast cancer. Molecular Medicine 13 (7-8), pp.396-406.